|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000197043 |
Summary for ANXA6 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000197043 | Gene symbol | ANXA6 |
| Gene name | annexin A6 | |
| HGNC | 544 | |
| Entrez ID | 309 | |
| Gene type | protein_coding | |
| Synonyms | ANXA6| | |
| UniProtAcc | P08133 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for ANXA6 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ANXA6 | 4.73e+03 | -1.07e+00 | 2.11e-01 | -5.06e+00 | 4.30e-07 | 1.69e-06 | HNSC |
| ANXA6 | 3.81e+03 | -1.04e+00 | 3.56e-01 | -2.91e+00 | 3.58e-03 | 1.70e-02 | ESCA |
| ANXA6 | 7.80e+03 | -1.59e+00 | 5.01e-01 | -3.18e+00 | 1.47e-03 | 4.76e-03 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for ANXA6 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for ANXA6 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| CHOL | cg21623671 | chr5:151157290 | CGI:chr5:151157530-151157857 | promoter,gene body | 4.72e-01 | 3.12e-01 | 1.97e+00 | 4.84e-02 | 4.84e-02 | 1.60e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUSC | cg03208031 | chr5:151158317 | CGI:chr5:151157530-151157857 | promoter | 1.88e-01 | 7.95e-02 | 3.22e+00 | 1.30e-03 | 3.09e-03 | 1.09e-01 |
| LUSC | cg00407659 | chr5:151158853 | CGI:chr5:151157530-151157857 | promoter | 6.36e-01 | 7.66e-01 | -3.22e+00 | 1.27e-03 | 3.06e-03 | -1.30e-01 |
| BLCA | cg00407659 | chr5:151158853 | CGI:chr5:151157530-151157857 | promoter | 6.05e-01 | 7.71e-01 | -3.91e+00 | 9.10e-05 | 3.74e-04 | -1.66e-01 |
| CHOL | cg21623671 | chr5:151157290 | CGI:chr5:151157530-151157857 | promoter,gene body | 3.12e-01 | 5.77e-02 | 2.65e+00 | 7.96e-03 | 1.92e-02 | 2.54e-01 |
| CHOL | cg03208031 | chr5:151158317 | CGI:chr5:151157530-151157857 | promoter | 1.75e-01 | 6.48e-02 | 2.21e+00 | 2.70e-02 | 3.50e-02 | 1.10e-01 |
| CHOL | cg19057001 | chr5:151158604 | CGI:chr5:151157530-151157857 | promoter | 3.80e-01 | 5.62e-01 | -2.21e+00 | 2.70e-02 | 3.50e-02 | -1.82e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for ANXA6 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| BRCA | exon_skip_445633 | 4.92e-01 | 6.79e-01 | -1.15e+01 | 8.70e-31 | 5.13e-29 | -1.87e-01 |
| READ | exon_skip_445633 | 5.57e-01 | 8.22e-01 | -3.94e+00 | 8.00e-05 | 3.54e-03 | -2.65e-01 |
Top |
RNA A-to-I editing events in TCGA for ANXA6 |
| ∗Please access CAeditome for RNA editing annotation. |
| Landscape of RNA editing events across multiple cancer types. |
 |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| STAD | ANXA6-004 | chr5_151111913_- | 5.60e-01 | 3.65e-01 | 2.22e+00 | 2.64e-02 | 4.96e-02 | 1.95e-01 |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for ANXA6 |
| TFs related to ANXA6. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ANXA6 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for ANXA6 |
| RBPs related to ES in ANXA6. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | ZCRB1 | exon_skip_445635 | 1.26e+01 | 3.24e-03 | 1.32e+01 | 9.96e-01 | Female-biased |
| UVM | PABPN1 | exon_skip_445611 | 9.02e+00 | 1.25e-03 | 9.51e+00 | 9.96e-01 | Female-biased |
| THYM | ESRP2 | exon_skip_445616 | 8.38e+00 | 2.55e-03 | 8.82e+00 | 9.92e-01 | Female-biased |
| THYM | ZCRB1 | exon_skip_445635 | 1.31e+01 | 9.96e-01 | 1.27e+01 | 3.27e-03 | Male-biased |
| COAD | PABPN1 | exon_skip_445611 | 9.07e+00 | 1.08e-02 | 9.40e+00 | 9.86e-01 | Female-biased |
| DLBC | ZC3H10 | exon_skip_445638 | 9.49e+00 | 9.92e-01 | 9.09e+00 | 5.40e-03 | Male-biased |
| LUAD | ZCRB1 | exon_skip_445635 | 1.29e+01 | 9.97e-01 | 1.25e+01 | 2.86e-03 | Male-biased |
| KIRP | PABPN1 | exon_skip_445611 | 9.16e+00 | 1.41e-02 | 9.46e+00 | 9.83e-01 | Female-biased |
| KIRP | ZC3H10 | exon_skip_445638 | 9.46e+00 | 9.93e-01 | 9.04e+00 | 3.91e-03 | Male-biased |
| KIRP | ZCRB1 | exon_skip_445635 | 1.32e+01 | 9.99e-01 | 1.25e+01 | 3.74e-04 | Male-biased |
| BRCA | ZCRB1 | exon_skip_445635 | 1.27e+01 | 9.84e-01 | 1.22e+01 | 1.53e-02 | Male-biased |
| ESCA | ZC3H10 | exon_skip_445638 | 8.91e+00 | 4.06e-03 | 9.47e+00 | 9.93e-01 | Female-biased |
| READ | PABPN1 | exon_skip_445611 | 8.99e+00 | 4.04e-03 | 9.40e+00 | 9.93e-01 | Female-biased |
| READ | ZC3H10 | exon_skip_445638 | 9.18e+00 | 5.09e-03 | 9.58e+00 | 9.92e-01 | Female-biased |
| PCPG | ZC3H10 | exon_skip_445638 | 9.08e+00 | 6.63e-03 | 9.43e+00 | 9.90e-01 | Female-biased |
| MESO | ZC3H10 | exon_skip_445638 | 9.44e+00 | 9.93e-01 | 8.99e+00 | 3.91e-03 | Male-biased |
| GBM | PABPN1 | exon_skip_445611 | 9.46e+00 | 9.82e-01 | 9.15e+00 | 1.50e-02 | Male-biased |
| GBM | ZCRB1 | exon_skip_445635 | 1.25e+01 | 9.74e-04 | 1.31e+01 | 9.99e-01 | Female-biased |
| PAAD | ZC3H10 | exon_skip_445638 | 9.10e+00 | 4.22e-03 | 9.47e+00 | 9.93e-01 | Female-biased |
| PAAD | ZCRB1 | exon_skip_445635 | 1.26e+01 | 2.35e-03 | 1.30e+01 | 9.97e-01 | Female-biased |
| KIRC | PABPN1 | exon_skip_445611 | 9.03e+00 | 6.09e-03 | 9.39e+00 | 9.91e-01 | Female-biased |
| KICH | ZC3H10 | exon_skip_445638 | 9.11e+00 | 3.34e-03 | 9.53e+00 | 9.94e-01 | Female-biased |
| HNSC | PABPN1 | exon_skip_445611 | 9.08e+00 | 1.31e-02 | 9.39e+00 | 9.84e-01 | Female-biased |
| HNSC | ZC3H10 | exon_skip_445638 | 9.01e+00 | 5.61e-03 | 9.39e+00 | 9.91e-01 | Female-biased |
| ANXA6 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs1422964 | chr5:144640917:C:T | - | 0.0595829821256754 | 0.017064899520503 | LUAD | Female-baised eQTL |
| rs17702948 | chr5:144598447:T:C | - | 0.0595132177538435 | 0.0178298478325643 | LUAD | Female-baised eQTL |
| rs1368290 | chr5:144654314:T:C | - | 0.0582210800744594 | 0.0209828437976893 | LUAD | Female-baised eQTL |
| rs35087376 | chr5:144600663:T:C | - | 0.0584850852056099 | 0.0212542946228515 | LUAD | Female-baised eQTL |
| rs35216411 | chr5:144617013:G:C | - | 0.0584850852056099 | 0.0212542946228515 | LUAD | Female-baised eQTL |
| rs6873273 | chr5:144594406:T:G | - | 0.0542344379091452 | 0.021391604173688 | LUAD | Female-baised eQTL |
| rs150790895 | chr5:144625365:C:T | - | 0.0577859062906462 | 0.0242281267294179 | LUAD | Female-baised eQTL |
| rs79051645 | chr5:144626243:C:T | - | 0.0577859062906462 | 0.0242281267294179 | LUAD | Female-baised eQTL |
| rs149836147 | chr5:144628488:A:G | - | 0.0577859062906462 | 0.0242281267294179 | LUAD | Female-baised eQTL |
| rs13181387 | chr5:144631414:C:T | - | 0.0577859062906462 | 0.0242281267294179 | LUAD | Female-baised eQTL |
| rs35987098 | chr5:144631658:G:A | - | 0.0577859062906462 | 0.0242281267294179 | LUAD | Female-baised eQTL |
| rs34130847 | chr5:144632857:C:T | - | 0.0577859062906462 | 0.0242281267294179 | LUAD | Female-baised eQTL |
| rs17451641 | chr5:144651025:A:G | - | 0.0561634394943463 | 0.0297650629693816 | LUAD | Female-baised eQTL |
| rs17451662 | chr5:144651191:C:A | - | 0.0561634394943463 | 0.0297650629693816 | LUAD | Female-baised eQTL |
| rs72804441 | chr5:144652292:A:G | - | 0.0561634394943463 | 0.0297650629693816 | LUAD | Female-baised eQTL |
| rs2217634 | chr5:144653053:G:T | - | 0.0561634394943463 | 0.0297650629693816 | LUAD | Female-baised eQTL |
| rs35833913 | chr5:144645916:T:C | - | 0.0552888813993388 | 0.0342214458918273 | LUAD | Female-baised eQTL |
| rs72804427 | chr5:144642489:C:T | - | 0.0573687328323646 | 0.0348370734220102 | LUAD | Female-baised eQTL |
| rs35319417 | chr5:144647127:T:A | - | 0.0551645098076863 | 0.0353292420474325 | LUAD | Female-baised eQTL |
| rs28565988 | chr5:154507894:C:T | - | 0.0603346419036331 | 0.0357278434394258 | LUAD | Female-baised eQTL |
| rs66755232 | chr5:144607332:T:G | - | 0.0572277689781817 | 0.0360847009208053 | LUAD | Female-baised eQTL |
| rs34435175 | chr5:144609791:T:C | - | 0.0572277689781817 | 0.0360847009208053 | LUAD | Female-baised eQTL |
| rs35575909 | chr5:144586575:G:T | - | 0.0549374938093597 | 0.0362774250218836 | LUAD | Female-baised eQTL |
| rs1432671 | chr5:144587705:G:C | - | 0.0549374938093597 | 0.0362774250218836 | LUAD | Female-baised eQTL |
| rs13176800 | chr5:144588301:G:A | - | 0.0549374938093597 | 0.0362774250218836 | LUAD | Female-baised eQTL |
| rs3861859 | chr5:144599470:C:T | - | 0.0569599980842423 | 0.0381622939033621 | LUAD | Female-baised eQTL |
| rs17450961 | chr5:144584606:G:C | - | 0.0549545491117034 | 0.0385548178094225 | LUAD | Female-baised eQTL |
| rs17385203 | chr5:144584129:G:A | - | 0.0547603983862887 | 0.0393076298682202 | LUAD | Female-baised eQTL |
| rs13161148 | chr5:144586868:G:C | - | 0.0543512311766926 | 0.0406768973712409 | LUAD | Female-baised eQTL |
| rs2081032 | chr5:144614427:C:T | - | 0.0549704703997614 | 0.0418476383709591 | LUAD | Female-baised eQTL |
| rs144854522 | chr5:144588777:G:A | - | 0.0541734521202523 | 0.0419841358139731 | LUAD | Female-baised eQTL |
| rs7737144 | chr5:144656427:G:A | - | 0.058592350628725 | 0.0420523360001739 | LUAD | Female-baised eQTL |
| rs11957385 | chr5:144535702:G:A | - | 0.0500835350032451 | 0.0431547717369171 | LUAD | Female-baised eQTL |
| rs1549234 | chr5:144639961:G:T | - | 0.05595166284439 | 0.043758911705462 | LUAD | Female-baised eQTL |
| rs13181693 | chr5:144586750:A:G | - | 0.0523028486690501 | 0.0477287913345794 | LUAD | Female-baised eQTL |
| rs929751 | chr5:144621504:C:T | - | 0.055437914246142 | 0.0481084788594148 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs12173156 | chr5:158295049:C:T | - | -0.0883293955005954 | 0.0233059052836805 | THCA | Male-baised eQTL |
| rs3792837 | chr5:147394119:G:A | - | 0.0689072439715236 | 0.0325092971999436 | LIHC | Male-baised eQTL |
| rs17106606 | chr5:147383526:C:G | - | 0.0674479281760137 | 0.0479476612469193 | LIHC | Male-baised eQTL |
| rs17595504 | chr5:155254380:A:G | - | 0.136514523287772 | 0.000413023522725764 | LGG | Male-baised eQTL |
| rs17654424 | chr5:155255063:G:A | - | 0.136514523287772 | 0.000413023522725764 | LGG | Male-baised eQTL |
| rs12518515 | chr5:155249181:G:T | - | 0.122743895588446 | 0.00291372086039513 | LGG | Male-baised eQTL |
| rs112403687 | chr5:155250053:G:T | - | 0.122743895588446 | 0.00291372086039513 | LGG | Male-baised eQTL |
| rs112451302 | chr5:155236816:G:A | - | 0.114040620176209 | 0.00513463467746186 | LGG | Male-baised eQTL |
| rs56947465 | chr5:155239584:G:A | - | 0.114730267823597 | 0.00681407767755789 | LGG | Male-baised eQTL |
| rs113027398 | chr5:155244633:G:C | - | 0.114590890146321 | 0.00699476416252596 | LGG | Male-baised eQTL |
| rs73291994 | chr5:155228596:C:T | - | 0.109646193071108 | 0.0124785241688688 | LGG | Male-baised eQTL |
| rs17653878 | chr5:155229520:G:A | - | 0.109646193071108 | 0.0124785241688688 | LGG | Male-baised eQTL |
| rs76253066 | chr5:155229248:C:T | - | 0.108456333850011 | 0.0151783998520223 | LGG | Male-baised eQTL |
| rs58858647 | chr5:155234055:G:C | - | 0.108456333850011 | 0.0151783998520223 | LGG | Male-baised eQTL |
| rs58883939 | chr5:155234102:A:C | - | 0.108456333850011 | 0.0151783998520223 | LGG | Male-baised eQTL |
| rs17575789 | chr5:155228079:A:C | - | 0.0976443349862691 | 0.0293443660085851 | LGG | Male-baised eQTL |
| rs78883938 | chr5:145104775:G:A | - | 0.104882752271871 | 0.0111786596255378 | BLCA | Male-baised eQTL |
| rs1981626 | chr5:145148892:T:C | - | -0.0823261122824075 | 0.0208362784286771 | BLCA | Male-baised eQTL |
| rs1347145 | chr5:151279716:A:T | - | 0.0697896818339188 | 0.00871605027717203 | COAD | Male-baised eQTL |
| rs10071465 | chr5:151091816:G:A | - | 0.058757242533769 | 0.0154272999416624 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000197043 |
| CpG Site: cg15892650 | |
| Position to Gene: gene | |
| Male Effect: -0.423448365110143 | |
| Female Effect: - | |
 | Gene ID: ENSG00000197043 |
| CpG Site: cg14870539 | |
| Position to Gene: gene,exon,UTR | |
| Male Effect: -0.33240875710543 | |
| Female Effect: - | |
 | Gene ID: ENSG00000197043 |
| CpG Site: cg18643093 | |
| Position to Gene: gene | |
| Male Effect: -0.402795578257348 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg15892650 | chr5:151145074 | gene | -0.423448365110143 | 1.7420850884741e-09 | -0.42917211761252755 | 9.252298806523695e-13 | LIHC |
| cg14870539 | chr5:151151191 | gene,exon,UTR | -0.33240875710543 | 3.08093041342426e-10 | -0.39806348667069263 | 2.058994439580406e-12 | LGG |
| cg18643093 | chr5:151141696 | gene | -0.402795578257348 | 2.49894526223456e-07 | -0.33269838634566873 | 6.737358054939743e-09 | LGG |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_445633 | chr5:151110626:151110644 | In-frame | rs11750722 | chr5:151508364:A:G | Distant upstream | 0.0714637491051835 | 0.00912988649232164 | COAD | Female-baised sQTL |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_445633 | chr5:151110626:151110644 | In-frame | rs6896664 | chr5:151885713:A:G | Distant upstream | -0.0334743115310319 | 0.0102841921107147 | LUSC | Male-baised sQTL |
| exon_skip_445633 | chr5:151110626:151110644 | In-frame | rs6892117 | chr5:151885424:A:G | Distant upstream | -0.0324715864434003 | 0.0188968078919609 | LUSC | Male-baised sQTL |
| exon_skip_445633 | chr5:151110626:151110644 | In-frame | rs3763011 | chr5:151025142:G:A | Distant downstream | 0.0341499662693205 | 0.0486604038495686 | LUSC | Male-baised sQTL |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of ANXA6 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000197043 | ANXA6 | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
| ENSG00000197043 | ANXA6 | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |
| ENSG00000197043 | ANXA6 | C0026998 | Acute Myeloid Leukemia, M1 | 1 | CTD_human |
| ENSG00000197043 | ANXA6 | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
| ENSG00000197043 | ANXA6 | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
| ENSG00000197043 | ANXA6 | C1879321 | Acute Myeloid Leukemia (AML-M2) | 1 | CTD_human |
| ENSG00000197043 | ANXA6 | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
| ENSG00000197043 | ANXA6 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
| ENSG00000197043 | ANXA6 | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
